Delivery Order SPE2DB22D9205-SPE2DB24FZF93
- Not listed
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of NUCALA 100 MG/ML auto-injectors. The potential value of this contract is $5,678.70, with a completion date of February 27, 2024. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler based in Park Ridge, Illinois that provides a wide range of pharmaceutical products and medical supplies to U.S. government...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $3,785.80 contract is for the supply of NUCALA 100 MG/ML AUTO-INJECTOR medical products. This order is part of DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a wide range of...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $3,785.80 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, which has a completion date of March 21, 2024, is for the supply of NUCALA 100 MG/ML auto-injectors to support the medical needs of military personnel and their dependents. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $26,500.60 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of the pharmaceutical product NUCALA 100 MG/ML AUTO-INJECTORML. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to $499,999,999, which allows the DLA to issue delivery orders for a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $45,429.60 to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide NUCALA 100 MG/ML AUTO-INJECTORML. This order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which enables the DLA to issue delivery orders for a comprehensive range of pharmaceutical items to support the medical supply...
- The U.S. Defense Logistics Agency awarded a firm-fixed-price delivery order contract worth $3,785.80 to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide NUCALA 100 mg/mL auto-injectors. This order is part of a larger indefinite-delivery contract (DLA Contract #4600082013) valued at up to $4,999,999 through 2025, which enables DLA to issue delivery orders for a broad range of pharmaceutical products to support military health facilities worldwide. DMS Pharmaceutical Group...
- The U.S. Defense Logistics Agency awarded a $7,571.60 firm-fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, for the pharmaceutical product NUCALA 100 MG/ML AUTO-INJECTORML. This order was placed under DMS Pharmaceutical Group's existing indefinite delivery contract 4600082013 with the Defense Logistics Agency, which has a total potential value of up to $4,999,999 through 2025. The contract enables the DLA to issue delivery orders for a broad range of...
- The U.S. Defense Logistics Agency (DLA) has awarded a Firm Fixed Price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $11,357.40, is for the delivery of NUCALA 100 MG/ML AUTO-INJECTORML. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999, to provide a comprehensive range of pharmaceutical items...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $3,785.80 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of NUCALA 100 MG/ML AUTO-INJECTORML, a biologic medication, to support the recurring medical supply needs of military health facilities worldwide. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) that...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the delivery of NUCALA 100 MG/ML AUTO-INJECTOR medical devices. The contract has a potential value of $11,357.40 and a completion date of February 23, 2024. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler based in Park Ridge, Illinois that provides a wide range of pharmaceutical products and medical...
- SPE2DB22D9205Indefinite Delivery Contract
- SPE2DB22D9205-SPE2DB24FZF93Delivery Order
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed-price delivery order contract worth $3,785.80 to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of NUCALA 100 MG/ML auto-injectors. This order is issued under DMS Pharmaceutical Group's existing indefinite delivery contract with DLA, contract 4600082013 under the SPE2DB program, valued at up to $4,999,999 through 2025. This larger contract enables DLA to place delivery orders for a broad range of pharmaceutical products to support the medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler based in Park Ridge, Illinois that has extensive experience providing brand-name and generic drugs, biologics, and other medical supplies to U.S. government agencies, particularly the Department of Veterans Affairs and Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 3/5/24 |